Arrowhead Pharmaceuticals, Inc. (ARWR)
Arrowhead Pharmaceuticals Market Cap : 8.571B for April 7, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Sarepta Therapeutics, Inc. | 2.425B |
| Eli Lilly & Co. | 834.48B |
| Sanofi | 112.38B |
| Johnson & Johnson | 568.21B |
| ACADIA Pharmaceuticals, Inc. | 3.768B |
Market Cap Related Metrics
| PE Ratio | 39.85 |
| PS Ratio | 7.724 |
| Price to Book Value | 15.10 |
| Price to Free Cash Flow | 25.77 |
| Price | 61.20 |
| Earnings Yield | 2.51% |
| Operating PE Ratio | 28.04 |
| Normalized PE Ratio | 39.85 |